Harris' 'Medicare at Home' Plan Would Fail To Make At-Home Care Affordable
Harris' plan to extend at-home care to Medicare recipients is yet another example of wasteful spending.
Harris' plan to extend at-home care to Medicare recipients is yet another example of wasteful spending.
As with Biden, you can count on Harris to expand government programs.
The state has been demanding that TV stations remove political ads in support of a reproductive freedom amendment on the ballot this year.
Even light-intensity exercise has noticeable health benefits, and going for a walk is better than hoping the government will fix the healthcare system.
Healthcare promises always come with high costs.
As it stands, the program effectively redistributes money from younger and poorer people to richer people.
A recent American Cancer Society study reports a negligible risk from passive smoking, shedding new light on the uproar over a 2003 paper.
These policies may sound good on paper—but they would be disastrous in reality.
When they entered the White House, the budget deficit was a pandemic-influenced $2.3 trillion, and it was set to fall to $905 billion by 2024. It's now twice what it was supposed to be.
Season 2, Episode 6 War on Drugs
How the FDA and DEA overrule the interests of doctors and patients.
"Right now, we need to get ourselves at least to a balanced budget, and that involves cutting a lot of the third rails of American politics," the Libertarian presidential nominee tells Reason.
Both presidential candidates (and their running mates) seem confused about the constraints imposed by the First Amendment.
Not only are microplastics essentially unavoidable, but the alleged harm they pose has been wildly overblown.
Plus: Massachusetts NIMBYs get their day in court, Pittsburgh one-step forward, two-steps back approach to zoning reform, and a surprisingly housing-heavy VP debate.
On Call, Anthony Fauci's new memoir, can't disguise the damage caused by his COVID-19 policies.
The medication shouldn't be this controversial.
Season 2, Episode 5 Podcasts
How restrictions on telemedicine are forcing doctors to choose between following the law and obeying their ethical obligations.
Organ donations in the U.S. are controlled by a network of federally sanctioned nonprofits, and many of them are failing.
In the Netherlands, kids grow up with more independence than in the United States.
Special interests and government prevent the free market from working the way it should in the healthcare industry, making many Americans poorer and sicker.
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical company.
If the former president wins the 2024 race, the circumstances he would inherit are far more challenging, and several of his policy ideas are destructive.
Season 2, Episode 4 Podcasts
Also: Could legalizing the sale of kidneys and other organs save lives?
Both Donald Trump and Kamala Harris support supply-side tactics that are worse than ineffective.
Reason's Nick Gillespie asked former President Donald Trump about how he plans to bring down the national debt.
This legislation could save many lives by giving tax credits to kidney donors. But it would not be as good as full legalization of organ sales.
One thing seems clear: Drug warriors do not deserve credit for the turnaround, although they deserve blame for the previous explosion in fatal overdoses.
Season 2, Episode 3 Health Care
Part Two: How Certificate of Need laws limit access to health care, and why those rules can be so difficult to dislodge.
Despite anti-immigrant rhetoric, the foreign-born account for nearly 20 percent less public health spending than those born in America.
America's COVID celebrity is facing scrutiny for funding risky research that may have sparked the pandemic—and for allegedly covering it up.
This Kentucky Republican won't stop until he finds a state willing to make legal room for ibogaine, a drug he calls "God's medicine."
The FDA’s latest nutrition rules target dried cherries and cranberries, putting small farmers at risk while offering zero benefits to consumers.
America's COVID celebrity is facing scrutiny for funding risky research that may have sparked the pandemic—and for allegedly covering it up.
Plus: The Senate wrestles with IVF funding, a dictator dies, and SpaceX passengers conduct the first-ever private spacewalk.
Season 2, Episode 2 Health Care
Too often, it's government bureaucrats acting under the influence of special interests and against the wishes of doctors and patients, with sometimes tragic results.
An FDA advisory committee concluded that MDMA's benefits had not been shown to outweigh its risks.
Each candidate made some good points about reproductive freedom and each told some major whoppers.
t makes case that enormous benefits of organ markets create a strong presumption in favor of legalization that standard objections don't even come close to overcoming.
His new stance could encourage Vice President Kamala Harris to emphasize her opposition to federal marijuana prohibition.
Season 2, Episode 1 Free Markets
Cuban's Cost Plus Drugs project brings a bit of free market flair to the health care industry, but the lack of meaningful price signals is only part of the problem.
The host of Why We Can't Have Nice Things returns to discuss the podcast's second season, which focuses on how government makes Americans poorer and sicker.
Season 2 Podcasts
A new season brings six new stories about how the government is making Americans poorer and sicker.
Plus: Kamala Harris' big night, Japan ignores climate critics, Rio cops lose their minds, and more...
Debate is one of the best ways to get closer to the truth. At least Kennedy is willing to do so.
The Meta CEO says his platforms will not blindly obey the bureaucrats again.
Economist Tyler Cowen argues the answer is "yes." But much depends on what kind of mobility we're talking about.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10